04.26.24
Huningue, France – Firalis Molecular Precision (FMP), a CAP-accredited fast-growing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces its development into a Certified Olink Service Provider, showcasing its proficiency in using advanced proteomics analysis tools.
This certification, granted by Olink, a leader in the field of proteomics technology, acknowledges Firalis Molecular Precision’s capability in utilizing a range of panels for proteomics analysis, including the Flex, Target 48 & 96, Explore HT, and Explore 384-plex panels.
The certification process involved rigorous evaluation of Firalis Molecular Precision’s proteomics team and methodologies. Through their relentless efforts, the team has successfully passed the Olink® concordance test, demonstrating adherence to Olink Analysis Service standards. This achievement ensures the highest level of data accuracy and reliability in proteomics analysis.
This includes passing the test for the Olink® Explore HT, Olink® Target 96, and Olink® Target 48 panels.
“We are thrilled to achieve certification as an Olink Service Provider,” said Aurélien Virciglio, Head of proteomics laboratory at Firalis Molecular Precision. “This certification validates our commitment to excellence in proteomics analysis and underscores our dedication to providing our sponsors with the highest quality and tailored solutions.”
Firalis Molecular Precision’s proteomics services are invaluable for clients seeking biomarker discovery and insights into the molecular mechanisms underlying diseases to develop tailored treatments and personalized healthcare strategies, leading to improved patient outcomes.
For more information about Firalis Molecular Precision’s proteomics services, visit Proteomics Services.
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
With headquarters in Huningue, France, and a presence in Cambridge, Mass., FMP is renowned for its commitment to innovation and excellence.
Leveraging cutting-edge technologies, FMP offers a comprehensive suite of bioanalytical services encompassing biobanking, multiomics-driven analyses (including genomics, proteomics, transcriptomics, lipidomics, and metabolomics), as well as omic data analysis, assay development, and custom in vitro diagnostic (IVD) kit manufacturing.
FMP’s mission is to empower healthcare professionals, researchers, and biopharmaceutical entities with the tools and solutions they need to drive progress towards better patient care and a more personalized medicine.